Phenylketonuria E70.00

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

foetal disease; oligophrenia phenylpyruvica; Pyruvic acid oligophrenia

History
This section has been translated automatically.

Fölling, 1934; Jervis, 1953; Morgan 1786;

Definition
This section has been translated automatically.

Hereditary enzyme defect of phenylalanine hydroxylase with oligophrenia and lack of pigment.

Occurrence/Epidemiology
This section has been translated automatically.

Worldwide spread. Most common genetic defect of amino acid metabolism. Incidence (Germany): 1/5.000-16.000 births. More frequent in the population of Turkish origin (especially due to the increased incidence of consanguine marriages).

Etiopathogenesis
This section has been translated automatically.

Autososomal recessively inherited enzyme defect due to mutations of the phenylalanine hydroxylase gene (PAH gene; gene locus: 12q24.1) with consecutive reduction or complete absence of phenylalanine hydroxylase and resulting tyrosine deficiency in the blood and internal organs.

Clinical features
This section has been translated automatically.

Integument: Light skin, light blond hair, blue eyes (lack of tyrosine leads to reduced melanin synthesis). Sensitivity to light, hyperhidrosis with a mouse-like odor. Dry, pityriasiform reed skin. In 20-50% of cases symptoms of atopic eczema.

Extracutaneous manifestations: among others oligophrenia, seizures.

Laboratory
This section has been translated automatically.

Phenylalanine in plasma > 600 µmol/l (10 mg/dl). Detection of phenylacetic acid, phenylpyruvic acid and their metabolites in urine. Phenylketonuria is diagnosed by screening on the 4th/5th day of life (Guthrie test).

Diagnosis
This section has been translated automatically.

Early childhood: green coloration of the urine with 5% iron-III-chloride solution or Phenistix stripes.

Therapy
This section has been translated automatically.

Skin changes: Skin care with oily external agents (e.g. base cream (DAC), ash base ointment, linola cream). Oil baths such as Balneum Hermal F, Linola Fett N oil bath.

Start early with a diet low in phenylalanine! Purchase of suitable food from pharmacies and hospitals. Manufacturer: e.g. SHS-Gesellschaft für klinische Ernährung mbH, Happenbacher Str. 5, 74074 Heilbronn, P.O. Box 3061.

Literature
This section has been translated automatically.

  1. Acosta PB et al (2003) Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy. J Am Diet Assoc 103: 1167-1173
  2. Fölling A (1934) On the excretion of phenylpyruvic acid in the urine as a metabolic abnormality in combination with imbecillization. Hoppe-Seylers Z Physiol Chem 227: 169-176
  3. Jervis GA (1953) Phenylpyruvic oligophrenia deficiency of phenylalanine-oxidizing system. Proc Soc Exper Biol Med 82: 514-515
  4. Jervis GA (1955) Studies on phenylpyruvic oligophrenia: the position of the metabolic error. J Biol Chem 169: 651-656
  5. Meli C et al (2002) Dietary control of phenylketonuria. Lancet 360: 2075-2076
  6. Muntau AC (2002) Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N Engl J Med 347: 2122-2132
  7. Walter JH et al (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360: 55-57
  8. Wilcken B et al (2003) Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 348: 2304-2312

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 29.10.2020